(Q37686143)

22 August 2017

1 reference

title

The role of testosterone in type 2 diabetes and metabolic syndrome in men. (English)

1 reference

22 August 2017

0 references

1 reference

1 reference

1 reference

Farid Saad

1

1 reference

22 August 2017

language of work or name

1 reference

1 November 2009

1 reference

Arquivos Brasileiros de Endocrinologia e Metabologia

22 August 2017

published in

1 reference

22 August 2017

volume

53

1 reference

22 August 2017

issue

8

1 reference

22 August 2017

page(s)

901-907

1 reference

The role of testosterone in the metabolic syndrome: a review

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Testosterone in obesity, metabolic syndrome and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Testosterone concentration in young patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

The effect of testosterone supplement on insulin sensitivity, glucose effectiveness, and acute insulin response after glucose load in male type 2 diabetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

More than eight years' hands-on experience with the novel long-acting parenteral testosterone undecanoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Androgen treatment of abdominally obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in a geriatric rehabilitation unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Low serum testosterone and mortality in male veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Low serum testosterone and mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302009000800002

10.1590/S0004-27302009000800002

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference